Read + Share
Amedeo Smart
Independent Medical Education
Jeon C, Kang SH, Kim SB, Paik NS, et al. Safety and Effectiveness of Trastuzumab Biosimilar SB3 in Korean Patients, a Post-Marketing Surveillance Study. Oncology 2024;102:465-475.PMID: 37899039
Email
LinkedIn
Privacy Policy